Trials / Completed
CompletedNCT01538498
Development for the Peritoneal Carcinomatosis Index (PCI) in Ovarian Cancer
A Clinical Trial to Develop a Peritoneal Carcinomatosis Index (PCI) in Ovarian
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 134 (actual)
- Sponsor
- National Cancer Center, Korea · Other Government
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
* Primary objectives: To develop peritoneal carcinomatosis index (PCI) for ovarian cancer, tubal cancer and primary peritoneal cancer that can represent perioperative intraperitoneal tumor burden objectively * Secondary objectives: To establish the relationship and find out clinical significance between PCI, tumor location and tumor characteristics
Detailed description
Patients with primary ovarian cancer * Informed consent * Digital photography \& Checking PCI (tumor size, number, and Characteristics) * Postoperative surveillance(tumor marker, image and physical examination) 1. Developing the best fitting PCI model to reflect recurrence-free survival and overall survival * Selection of items * Weighting by items and tumor characteristics 2. Analysis of prognostic impact of PCI compared to conventional staging system (FIGO stage) for ovarian cancer
Conditions
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2012-11-01
- Completion
- 2013-02-01
- First posted
- 2012-02-24
- Last updated
- 2013-03-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01538498. Inclusion in this directory is not an endorsement.